chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had itchy, scratchy throat on the 12th in afternoon. Sunday, I woke up fully congested. I went to the pharmacy to get decongestant and I ended up going into the clinic, 13th, to get checked. There, they looked in my nose and she said it was stuffy and goopy. She wasn't convinced it was an infection so told me to wait until. On Monday, Tuesday and Wednesday, I worked all day and was exhausted when I went home and on Wed, 16th, I started taking the antibiotic, I just felt bad and felt really stuffy. Got a low-grade fever, was taking Tylenol. I felt went really bad and I went as a walk-in to my primary care doctor. She said to let whatever it was to take its course. I had a little bout of nausea that would come here and there (she said that was from the drip in the back of my throat). Thursday night, I got dehydrated because I wasn't drinking enough or eating enough, nothing sounded good, though. I had a really bad headache and I passed out, woke up very quickly though. I woke up and felt nauseated. Husband took me to ER. They did an EKG and other testing including COVID test, positive result. Zinc; vitamin D, I started taking it every day instead of three days a week and added vitamin C and the elderberry gummies with immune support. I drank 7-8 bottles of water with electrolytes in it a day. I was in bed for three days without getting up. I got a pulse oximeter (as instructed by nurse at ER), never got below 90. The virus never went into my chest of my lungs and I never had to use my inhaler one time. I have about 90% of taste back now; I have some of my smell back. I didn't go back to work until 29th of June and I was just working short days as I was still very, very tired. About 3PM the tiredness would hit. Into this week, I'm not as tired anymore. I don't have 100% of energy back for exercising back.
When pt was brought to my office for the next set of vaccines, his parents described 8 hours of high - pitched screaming post the prev vaccines.  No other problems were described
Patient is a 17 y/o female who received her first dose of Moderna vaccine.  Patient was not eligible to receive Moderna due to her age.   Father of patient signed consent for daughter to receive vaccine.  Medical doctor contacted regarding vaccine being given.  No negative side effects at this time.  Patient is schedule to receive second dose of vaccine per medical doctor's consent.  Father of patient contacted by Medical doctor, informing him that his daughter should not have been given the Moderna vaccine due to her age.
Information has been received from a medical assistant referring to a 26 year old female patient. On an unknown date in April 2010 (reported as 5 years ago), the patient was vaccinated with the first dose of GARDASIL (dose, route and lot# unknown). ON 10-APR-2015 the patient was vaccinated with the second dose of GARDASIL 9 (dose, route and lot# unknown) inappropriate schedule of drug administration). No adverse effects were reported. Additional information has been requested.
Flushing, redness, numbness tingling to bilat hands, severe headache, and weakness to right hand today. Started approx 4 hours after receiving vaccines, was seen in ER given fluids and tylenol. Pt c/o continued symptoms 24 hours after vaccine.
under arm looks lighter; between her fingers and armpit looks white; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (under arm looks lighter) and SKIN DISCOLOURATION (between her fingers and armpit looks white) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. W8B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced SKIN DISCOLOURATION (under arm looks lighter) and SKIN DISCOLOURATION (between her fingers and armpit looks white). At the time of the report, SKIN DISCOLOURATION (under arm looks lighter) and SKIN DISCOLOURATION (between her fingers and armpit looks white) outcome was unknown. Not Provided          No concomitant medication was reported. Action taken with mRNA-1273 in response to the events was not applicable. Treatment medication included Hydrocortisone.   This case was linked to MOD-2021-083567 (Patient Link).
Information has been received from a physician concerning a 72 year old female who on 10/06/2006 was vaccainted with a dose of Varicella Zoster vaccine. On 10/09/2006 the pt complained of pain mid back radiating to under the right breast. On 10/10/06 the physician reported that no rash was currently present. it was reported that two days after vaccination the pt developed shingles. the pts husband reported that his wife was vaccainted at her primary care physicians office on 10/05/06. On 10/10/06, the pt revisited her primary care physician and was diagnosed with an outbreak of shingles. the physician prescribed Famvir 500 mg and Tylenol with Codeine 3. At the time of the report, the pt was coping with the pain and discomfort of shingles and had not recovered. Additional information has been requested.
Pt vaccinated with DTP/OPV took 3hr nap after shot, awoke crying, irritability, then constant screaming. Baby cried inconsolably all night, slept 15 min., Fever 101.8.
Pt presented to ED with diffuse rash.  Pt was treated with Benadryl, prednisone and topical hydrocortisone.  Pt released when stable.
Information has been received from a physician concerning a patient who "last week" on approximately 21-JUN-2010 was intended to receive ZOSTAVAX (Merck), was inadvertently administered subcutaneously a 0.5 ml dose of VARIVAX (Merck). No adverse symptoms reported. The patient's outcome was unknown. No further information is available.
pt awoke w/t103.5 on 3APR96 w/sl raised red rash;fever lasted x 4 days;taken to MD to r/o chicken pox, not chicken pox may be viral per MD;was very fussy w/fever;doing well now
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 31Aug2022 as dose 5 (booster), single (Lot number: Gj6739) at the age of 60 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 31Jul2022 as dose 4 (booster), single (Lot number: Fj4991) for covid-19 immunisation; BNT162b2 (BNT162B2), on 16Mar2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 09Apr2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 01Feb2022 as dose 3 (booster), single (Lot number: Fg3527), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Nerve damage" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Dec2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient was treated with Paxlovid from 22Dec2022 to 26Dec2022. The information on the batch/lot number for BNT162B2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300108245 same patient/vaccine, diff dose/event;
Not feeling well; Tired; Ache all over; Low energy level; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Low energy level), MALAISE (Not feeling well), FATIGUE (Tired) and PAIN (Ache all over) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced ASTHENIA (Low energy level). On an unknown date, the patient experienced MALAISE (Not feeling well), FATIGUE (Tired) and PAIN (Ache all over). At the time of the report, ASTHENIA (Low energy level), MALAISE (Not feeling well), FATIGUE (Tired) and PAIN (Ache all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.    Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: NNI
Patient received moderna vaccine and after removal of the needle, she began to bleed from the injection. She began to feel dizzy and lightheaded, face turned a bit white. We gave her water and gatorade and she began to feel better. We continued to monitor her for about 30 mins before she left
her left arm was sore; had spasms in her abdomen; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th July 2021, the patient received the 1st dose of Shingrix .5 ml. In July 2021, less than a week after receiving Shingrix, the patient experienced pain in arm and abdominal spasm. On an unknown date, the outcome of the pain in arm and abdominal spasm were unknown.   It was unknown if the reporter considered the pain in arm and abdominal spasm to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself. The patient received her first Shingrix vaccine a week ago, and her left arm was sore and she had spasms in her abdomen. No further information was reported. The reporter consented to follow up.
Patient had itchy, dry throat. BP 143/98 -- > 144/98 -- > 118/78 (11:09AM), HR 86 -- > 77 -- > 63, RR 16, O2 100% -- > 99%, Temp 99F -- > 98.8F. Given Benadryl 50 mg IM at 10:50AM. Patient stable and released from vaccination site at 11:21AM.
COVID-19 Infection: (+) 6/3. Asymptomatic on room air.
Chest pounding when trying to sleep.   Pulse rate was 109 the next morning.    Chills starting about 1:30 am and lasting until 3 am.    Nauseous about 5 am.
Patient began to get dizzy, had to lay down, was conscious  but a mildly y confused, nausea, dry heaving, complaining of headache with confusion getting worse and patient asking where she was.  911 called, patient was evaluated and cleared  and declined to go to ER for further work up
Anterior thigh (mild eryth & swelling) distal to injection site, non-tender about 5X6cm localized.
Woke up thirsty, went to get something to drink. Got dizzy while standing by fridge. Sat down started having palpitations. Broke out in sweats, hands and feet got tingly. Shortness of breath. After a while of it not going away I went to the ER.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown dates, patients were vaccinated with an improperly stored dose of ROTATEQ, lot # L035276, expiry date 09-JUN-2017; lot # L002042, expiry date 28-JUL-2016; lot # L008996, expiry date 01-DEC-2016; lot # L013188, Expiry date 02-NOV-2016; lot # L027726, expiry date 10-MAY-2017 ad lot # K016263, expiry date 26-JUN-2016 (dose, frequency and route of administration not reported). No adverse effect reported. The outcome of events was unknown. No product quality complaint (PQC) was involved. No further details provided. This is one of five reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a physician via a company representative concerning a female patient of unknown age.  The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with a dose of GARDASIL 9 (dose, lot number, expiration date, route of administration were not reported) for prophylaxis.       On an unknown date, a month after receiving the vaccine, the patient developed a knot on her arm at the injection site (injection site nodule). The outcome of the event was reported as not recovered/not resolved. The product quality complaint was not involved. The relatedness between the event and GARDASIL 9 was not reported. Additional information has been requested.
I spoke to the patient by phone at 14:21 pm on 11/21/18. She reported that she developed pain in the injection site on the left arm shortly after receiving the vaccinations above. She also reports that she has developed swelling in the injection site without redness. In addition, patient reports left arm pit swelling and a swollen nodule in the area of her left collar bone. She denies any fever, rash or shortness of breath. Given that tomorrow is Thanksgiving, I have asked the patient to go to the nearest Urgent Care immediately for further medical evaluation and management. I also provided her with my phone number for follow-up from the provider.
very stiff in his legs and then it traveled up to hips briefly and then in his shoulders for a longer period of time; very stiff in his legs and then it traveled up to hips briefly and then in his shoulders for a longer period of time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. This is the report for the male patients he reported with the same problem. This is report 2 of 3.   A 71 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Mar2021 15:00 (Lot number: EN6207) as dose 2, single and administered in arm left, administration date 23Feb2021 15:50 (Lot number: EN6202) as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), JOINT STIFFNESS (non-serious), outcome "unknown" and all described as "very stiff in his legs and then it traveled up to hips briefly and then in his shoulders for a longer period of time".  Additional Information: He was calling about the Pfizer covid vaccine. He was 71 years old and was asking if he should get the booster. 16Mar2021 was when he got the first dose and then 2 weeks later he got second dose. Two weeks after the second dose, around the 14th or 15th day, he became very stiff in his legs and then it traveled up to hips briefly and then in his shoulders for a longer period of time. The prior Vaccinations (with in 4 weeks), concomitant drugs, patient's medical history, relevant tests were reported as none. Specific relevant test for thromboembolic events with thrombocytopenia was none  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 2 month old patient with no pertinent medical history who was vaccinated PO with the first dose of ROTATEQ (no lot# given).  Concomitant vaccinations were received "within the same visit but specifics unknown."  "About 1-2 weeks post vaccination, the patient experienced diarrhea that was yellowish and had a rotavirus smell to it."  The patient sought unspecified medical attention.  No labs or diagnostic studies were performed.  Subsequently, the patient "had improved" and was noted to be recovered.  There was no product quality complaint.  Additional information has been requested.
Evening of vaccination developed left deltoid and neck pain that progressed to multiple muscle, joint and skin pain.  Alternating chills/sweats and severe fatigue.  Very similar to influenza without the respiratory symptoms.  This lasted approximately 2 days, then developed nausea and diarrhea with intermittent fatigue and chills/sweats.  Day 5 I feel better, but still have sweats, diarrhea and intermittent nausea.
Vaccine #1: Sore, tender at injection site. Symptoms start two hours post injection and resolved 24 hours post injection. No treatment.   Vaccine #2: Sore, tender, swollen at injection site;  headache; body aches; chills; fatigue. Symptoms started 2-3 hours post injection and resolved 43 hours after symptoms started. No treatment.
it has come to my knowledge that the nurse vaccinated a child under 12 years old. Unknown reaction.
increase of temperature; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 25Mar2021 (Lot number: EP6955) at the age of 61 years as dose 2, single and intramuscular, administered in arm left, administration date 04Mar2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (ongoing); "high cholesterol" (ongoing); "vitamin d deficiency" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE BESYLATE taken for hypertension (ongoing); ATORVASTATIN taken for blood cholesterol increased (ongoing); VITAMIN D [COLECALCIFEROL] taken for vitamin d deficiency (ongoing); MAGNESIUM (ongoing). The following information was reported: BODY TEMPERATURE INCREASED (non-serious), outcome "unknown", described as "increase of temperature". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Prior vaccinations (within 4 weeks), any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s): included none. Relevant tests included none. Patient had increase of temperature after each vaccination.  Follow-up attempts are completed. No further information is expected.
both shoulders ached; This is a spontaneous report from a contactable consumer (patient's friend). An 80-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number and Expiration date: not reported) on an unspecified date as dose 2, single for COVID-19 immunisation. The vaccine was administered in a clinic. The patient's medical history included COVID-19 (tested positive for COVID in Dec2020) and asthmatic. The patient has no concomitant medications. The patient previously received the first dose of BNT162B2 on an unspecified date for COVID-19 immunisation and experienced compromised breathing, lethargy, general achiness, and heart thing (as reported)(recovered). On an unspecified date, after receiving the second dose, the patient experienced "both shoulders ached" and described like it was bursitis which persisted to this day (on the day of the report). The outcome of the event was not recovered.  Information on batch/lot number has been requested.
Patient has encephalopathy and severe scoliosis and has no muscle tone in her arms. Patient mother requested vaccination in her thigh as that is where patient receives other vaccines. Notification and approval made to Dr. per texting application and via phone call. Patient received first dose of covid vaccine in right thigh. Vaccine administered by LVN with proper instruction from PharmD.
42 y/o AD M RTC with L shoulder Px. Pt states his L Shoulder is completely frozen. Pt was given his JEV shot on 29JAN19, pt states the staff may have gone too deep with shot. Pt states when he woke up the next day he couldn't move his L arm at all. Pt states this is the worst PX of his life. Pt would like his L shoulder evaluated for damage done.
Two days after swelling and redness in arm which resolved but know anytime I get and insect bite or sting there is extreme swelling, redness, and itchiness which becomes quite severe that lasts over a week before starting to show any improvement. I have never had this type of reaction to any insect bites or stings before. It is much more than what occurs after a bite or sting and continues to enlarge.
diagnosed with shingles several days after receiving the first dose of the Moderna vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (diagnosed with shingles several days after receiving the first dose of the Moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (diagnosed with shingles several days after receiving the first dose of the Moderna vaccine). At the time of the report, HERPES ZOSTER (diagnosed with shingles several days after receiving the first dose of the Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not provided.
Widespread hives that began 12/27/21 with one patch on my right hip. Has spread to left hip, right thigh, both butt cheeks, both lower legs and chest.
h/a, sweats, light sensitivity, vomiting, nausea, fever, chills, body aches, abd cramps;meds synthroid, ASA;allergic to anti-inflammatory;
Vaccine was expired for 18  days. Given inadvertently due to confusion in extended dates. vaccine stored in refrigerator and not ultra-cold. Used ultra-cold extended date instead of 10 week expiration date.
lump in throat, dizzy, pressure in upper chest and back, chills, blood pressure dropped, sick to my stomach and feeling so weak. It started about 4 hours after the shot about 2:30 PM October 1, 2019.   Went to Emergency Dept
Chest pain; Chest tightness on her left side.; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest pain) and CHEST DISCOMFORT (Chest tightness on her left side.) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced CHEST PAIN (Chest pain) and CHEST DISCOMFORT (Chest tightness on her left side.). The patient was treated with NAPROXEN at a dose of 220 milligram. At the time of the report, CHEST PAIN (Chest pain) and CHEST DISCOMFORT (Chest tightness on her left side.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Acute pain in upper arm significantly more severe than flu vaccine, started almost immediately.  I did some aerobic exercise 1 hour after the vaccine.  Two hours after the vaccine, I started to feel minor body aches that increased in severity throughout the evening.  By bedtime movement was uncomfortable and I spend a largely sleep less night.  The next day,  was suffering from a low-grade fever (<100 F) and general body aches (that made it difficult to move), headache and minor stomach upset.  I took an advil to in the morning to decrease the symptoms.  I took another in the afternoon.  By the evening (after dinner) the symptoms significantly resolved.  I still have minor aches 40 hours after the vaccine but feel well enough to resume normal activity.  The most acute phase of the symptoms were severe enough that I would not have been able to go into work under normal (non-Covid) circumstances.    Symptoms are definitely NOT severe enough that I would ever consider NOT having the vaccination, but they are definitely the most notable reaction I've can every recall having to a vaccination.